drugset / Trial / NCT00651820

Effect of Collagenase on Healing and Scarring

NCT00651820 ↗

Phase 4 Completed 28 enrolled Healthpoint
RandomizedParallel-groupQuadruple-blindBasic science

Summary

A study to compare the rate of complete wound closure and quality of resulting scar at 3, 6 and 9 months, between dermatome-induced skin wounds treated with Collagenase Santyl Ointment versus vehicle alone.

Timeline

Start
2008-04
Primary completion
2009-11
Completion
2010-03

Outcome

Met primary endpoint

registry Collagenase Santyl Rate of Wound Closure vs Vehicle Rate to Complete Wound Healing; p <0.05; Paired-Prentice Wilcoxon (PPW) NCT00651820 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Collagenase Santyl Unknown — —

Indications

No indication recorded.